THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS CALGARY, Alberta, Jan. 15, 2026 (GLOBE NEWSWIRE) ...
Lombard Street Capital Corp. (TSXV: LSC.P) ("Lombard" or the "Corporation"), a capital pool company, is pleased to announce that it has changed its name to "Lithium Africa Corp." (the "Name Change") ...
The Fund’s Board of Directors approved the Reverse Split upon recommendation of the Fund’s investment manager, Thomas J. Herzfeld Advisors, Inc. (the “Investment Manager”). In recommending the Reverse ...
Zurich - January 15, 2026 - Amcor plc (NYSE: AMCR; ASX: AMC), a global leader in developing and producing responsible ...
SINGAPORE, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Bit Origin Ltd (NASDAQ: BTOG) (“Bit Origin” or the “Company”), today announced that its Board of Directors has approved a 1-for-60 reverse stock split of ...
Bit Origin (BTOG) on Thursday announced a 1-for-60 reverse stock split, effective January 20, 2026. "The reverse stock split ...
There will be no change to the ticker symbol (TSX: HFN) or CUSIP number for the ETF associated with the Name Change. The investment objective and strategy of the ETF, as outlined in the prospectus, ...
IRVINE, CA / ACCESS Newswire / January 15, 2026 / enVVeno Medical Corporation ("enVVeno Medical" or the "Company"), today ...
IRVINE, CA / ACCESS Newswire / January 15, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today announced that the Company's Board of Directors has approved a r ...
In connection with the name and ticker symbol changes, no further action is required from the Company's shareholders, and the Company's CUSIP number will remain unchanged. The changes are not expected ...
The Company's common shares are expected to begin trading on a post-consolidated basis at the opening of the market on January 20, 2026. Following the consolidation, the Company's common shares will ...
ESTERO, FL / ACCESS Newswire / January 14, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...